Understanding thyroid problems caused by cancer immunotherapy
Mechanisms of Thyroid Autoimmunity in Checkpoint Immunotherapy
This study, led by Dr. Melissa G. Lechner at UCLA, is looking into how cancer immunotherapy might cause some people to develop thyroid problems, and it aims to find out why this happens to some patients but not others, which could help make cancer treatments better for everyone.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10876467 on NIH RePORTER |
What this research studies
This research investigates how cancer immunotherapy can lead to thyroid autoimmunity, a condition where the immune system mistakenly attacks the thyroid gland. Led by Dr. Melissa G. Lechner at UCLA, the project utilizes advanced techniques such as mouse models and bioinformatics to explore the underlying mechanisms of this autoimmune response. By studying thyroiditis, a common side effect of immunotherapy, the research aims to uncover why some patients experience these adverse effects while others do not. The findings could help improve treatment strategies and patient outcomes in cancer care.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients receiving immune checkpoint inhibitor therapies for cancer who may be at risk for thyroid-related side effects.
Not a fit: Patients not undergoing cancer immunotherapy or those without thyroid issues are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better management of autoimmune side effects in cancer patients undergoing immunotherapy.
How similar studies have performed: Previous research has shown that understanding autoimmune responses in cancer treatment can lead to significant improvements in patient care, indicating that this approach has potential for success.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Lechner, Melissa G — University of California Los Angeles
- Study coordinator: Lechner, Melissa G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.